(Q43267079)

17 November 2017

title

The levonorgestrel intrauterine system: long-term contraception and therapeutic effects (English)

1 reference

17 November 2017

1 reference

1 reference

1 reference

Regine Sitruk-Ware

1

1 reference

17 November 2017

Pirjo Inki

series ordinal

2

1 reference

17 November 2017

language of work or name

1 reference

1 September 2005

1 reference

17 November 2017

1 reference

17 November 2017

volume

1

1 reference

17 November 2017

issue

2

1 reference

17 November 2017

page(s)

171-182

1 reference

Levonorgestrel-releasing intrauterine device

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

The levonorgestrel intrauterine system: a clinical perspective from the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Pharmacological profile of progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Benefit-risk assessment of the levonorgestrel intrauterine system in contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Pregnancy during the use of levonorgestrel intrauterine system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Ectopic pregnancy among non-medicated and copper-containing intrauterine device users: a 10-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Complications of the intrauterine device in nulliparous and parous women.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment cha

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

The levonorgestrel intrauterine system in contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Insertion of mirena after endometrial resection in patients with adenomyosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Treatments for heavy menstrual bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Neoplasia of the female reproductive tract: effects of hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Intrauterine application of progestins in hormone replacement therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Exogenous progestagens and the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Effects of a progestogen on normal human breast epithelial cell apoptosis in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

Amenorrhea associated with contraception-an international study on acceptability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.1.2.171

21 January 2018

Identifiers

DOI

10.2217/17455057.1.2.171

1 reference

17 November 2017

1 reference